Telo Genomics’ Post

Identifying reliable prognostic markers can be useful for managing patients with #MantleCellLymphoma (#MCL). Which biomarker is most suitable for these patients?

📰This study, published in Nature Communications, concluded that the divergent epigenomic reprogramming enforced by aberrant non-canonical NF-κB signaling potentiates transcriptional programs beneficial for multiple myeloma progression Abstract➡️https://lnkd.in/gUi3bYYP #MultipleMyeloma #myeloma #bloodcancer

This #BrainInjuryAwareness month 💡 Explore AI-enhanced biomarkers for accurate diagnoses and comprehensive treatment monitoring through our neuroimaging packages. Learn more: https://bit.ly/3wHU08f #Neuroimaging #AIBiomarkers #PreciseDiagnosis

🎥 Excited to share insights from Reza Rezaei, DVM, PhD, MBA on a powerful weapon against obesity—GDF15! This tiny protein is a key regulator of body weight, metabolism, and more. Beyond suppressing appetite, GDF15 also impacts heart health, cancer mechanisms, and metabolic diseases like MLD and NASH. Research on humanized mouse models is shedding light on GDF15's therapeutic potential, making it a promising target for innovative treatments. 🤔 Curious about the latest research? Share your thoughts on GDF15 in the comments, and let's explore its impact together! #obesityresearch #GDF15 #metabolichealth #innovativetherapies #cancerresearch #HeartHealth #MLD #NASH #humanizedmousemodels #therapeuticpotential #biotech #medicalresearch #cyagen #HUGOGT #HUGOUS

Discover how biomarkers are shaping the future of #Alzheimers disease detection and treatment. Quanterix is making strides in neurodegenerative research, helping identify crucial biomarkers that drive progress in drug development and patient care. Hear from David H. Wilson, VP of Clinical Strategy at Quanterix, on how this could reshape the way we approach Alzheimer’s. Read more: https://lnkd.in/gjS_hugG #AlzheimersResearch #Biomarkers #Neurodegeneration Quanterix

#TipofTheDay in #Pneumologia et al : - New Models for Generative #AI and Cellular Imaging can be useful as new biomarkers for Pulmonology ( #COPD / #Asthma), Gastroenterology, etc….Breaking Barriers in #Healthcare: 👉🏼🔗 https://lnkd.in/dmE3GSP2

🌟Spotlight on Orion🌟 Data in hours. Validation in days. Studies in weeks. Discover whole-slide precision spatial biology with Orion. Orion enables rapid, sub-cellular resolution scanning and analysis of patient biopsies for up to 20 biomarkers, with turnaround times to support large cohort studies and to inform patient responsiveness in immune therapy trials. Explore the Orion Platform, https://lnkd.in/g_FvDCG. #SpatialBiology #Biomarkers #RareCyte

🌟 IO360 starts tomorrow! Don't miss 🎤 Dr. Oscar P.'s lecture to discover how AI-driven spatial biomarkers can transform prospective patient enrollment in clinical trials. See you there! 🚀 https://hubs.li/Q02mdS5D0 #IO360 #clinicaltrials #biomarkers #spatialbiomarkers #spatialbiology #precisiononcology!

Reduced central #retinal artery flow and enlarged #optic nerve assessed by transorbital #ultrasound are potential biomarkers for significant ocular involvement in newly diagnosed giant cell #arteritis (GCA) patients. This inflammatory changes seems to be associated with extracranial vessel involvement, indicating a shared pathophysiological mechanism underlying both systemic and ocular manifestations of GCA. 🔗https://lnkd.in/dpja_4dj

Glioblastoma is a highly heterogeneous tumor whose pathophysiological complexities dictate both the diagnosis of disease severity as well as response to therapy. Conventional diagnostic tools and standard treatment regimens have only managed to achieve limited success in the management of patients suspected of glioblastoma. Extracellular vesicles (Exosomes) are an emerging liquid biopsy tool that has shown great promise in resolving the limitations presented by the heterogeneous nature of glioblastoma. Read more https://lnkd.in/eerPkJHE #Exosome #extracellularvesicles #kosheeka #biotech #research